ClinicalTrials.gg
CompletedNCT03088332Updated Aug 17, 2022

Evaluating the Efficacy and Results of Endoscopic Gastroplasty Performed Using Overstitch in Patients With Obesity.

An interventional study of Endoscopic gastroplasty in Obesity, sponsored by Kaiser Clinic and Hospital. Completed at 3 sites in Brazil. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2022-08-17.

Sponsored by Kaiser Clinic and Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Obesity is a chronic disease that has grown to epidemic characteristics in Brazil and around the world in recent years. Treatment for patients with class III or class II obesity with comorbidities is already well established, with bariatric surgery being the best option. However, there is no consensus as to the best treatment for cases of class I and class II obesity without comorbidities. The objective of this research will be to make a gastric tube similar to that obtained in surgical gastroplication however it will be created using intragastric endoscopic sutures. The procedures will be performed at the Endoscopy Service of the Mario Covas Hospital in São Paulo, SP. Data collection will be performed at the same location.

Read the detailed description

The objective of this research will be to make a gastric tube similar to that obtained in surgical gastroplication however it will be created using intragastric endoscopic sutures. The secondary objective will be to correlate demographic, endoscopic and laboratory data with the results of this procedure.

Patients and Methods: Patients with class I obesity with or without comorbidities and patients with class II obesity without comorbidities, irrespective of gender and ethnic background, from the state of São Paulo and other states of the country will be submitted to vertical endoscopic gastroplasty. The procedures will be performed at the Endoscopy Service of the Mario Covas Hospital in São Paulo, SP. Data collection will be performed at the same location.

Information will be obtained during the outpatient follow-up at the Hospital Mario Covas including demographic (gender, age), clinical (height, weight, time after procedure, systemic arterial hypertension, diabetes, dyslipidemia, smoking, alcohol consumption) and operative data (complications).

Preparation for the procedure: All the exams will be performed at the Hospital Mario Covas after the patients have fasted for at least 8 hours. The procedure will begin with the patient in left lateral decubitus under general anesthesia performed by an anesthesiologist. Endoscopic sutures will be performed using 2-0 prolene thread until a tubular-shaped stomach is formed similar to a vertical gastrectomy.

Recovery after the procedure: After the procedure and recovery from anesthesia, all patients will be discharged but only together with a companion. All patients will receive guidance and will remain in touch with a physician to report any adverse signs or symptoms.

Outcomes Primary outcome: To confirm the efficacy of endoscopic sutures in the primary treatment of obesity.

Secondary outcome: To evaluate the use of the endoscopic sutures in relation to demographic data.

02

Conditions studied

  • Obesity

Browse trials for

03

In context

Obesity

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's enrollment of 30 is below the median of 67 across 9,006 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Kaiser Clinic and Hospital is the lead sponsor of 11 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • > 30 and \< 36 with or without comorbidities
  • BMI > 36 and \< 40 without comorbidities

Exclusion criteria

Exclusion Criteria:

  • Prior gastric surgery
  • Use of anticoagulants
  • Psychiatric disorders
  • Severe esophagitis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Endoscopic gastroplasty

    Make a gastric tube similar to that obtained in surgical gastroplication however it will be created using intragastric endoscopic sutures.

    Procedure: Endoscopic gastroplasty

Interventions

  • ProcedureEndoscopic gastroplasty

    Vertical endoscopic gastroplasty

06

What researchers measure

Primary outcomes

  1. Weight loss

    Weight in Kg and Body Mass Index (BMI) in kilograms by meters squared

    Time frame: 48 weeks

Secondary outcomes

  1. Blood count

    Measured in cmm

    Time frame: 48 weeks

  2. Hb1AC

    Measured in percentage

    Time frame: 48 weeks

  3. Cholesterol

    Measured in mg/dL

    Time frame: 48 weeks

  4. Fasting blood glucose

    Measured in mg/dL

    Time frame: 48 weeks

  5. Procedural complications

    Complications related to the procedure, either at the time of the procedure (bleeding, perforation and suture rupture) or in the postoperative period, performing an endoscopy at 6 months and 1 year to evaluate the suture line.

    Time frame: At the time of procedure and at 6 months and 1 year follow-up period

07

Study locations

3 sites
  • Mario Covas Hospital
    Santo André, SP 09190-615, Brazil
  • Kaiser Day hospital
    Sao Jose do Rio Preto, SP, Brazil
  • 9 de Julho Hospital
    Sao Paulo, SP 01409-002, Brazil
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 17, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03088332
Lead sponsor
Kaiser Clinic and Hospital
Responsible party
Sponsor
First posted
Mar 23, 2017
Start date
Jun 1, 2017
Primary completion
Dec 31, 2017
Completion
Dec 31, 2020
Last update
Aug 17, 2022

Study contacts

Luiz Guatavo de Quadros, MD
principal investigator · Kaiser Clinica and Day Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion